Expression, localization and tau exon 10 splicing activity of the brain RNA-binding protein TNRC4

Human Molecular Genetics

Volumn 16, Issue 22, 2007, Pages 2760-2769

  Chapple, Paul J ^a,d   Anthony, Karen ^a   Martin, Teresa Rodriguez ^a   Dev, Arvind ^b   Cooper, Thomas A ^c   Gallo, Jean Marc ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; POLYGLUTAMINE; RNA BINDING PROTEIN; TAU PROTEIN; TRINUCLEOTIDE; TRINUCLEOTIDE REPEAT CONTAINING PROTEIN 4; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN FUNCTION; CARBOXY TERMINAL SEQUENCE; EXON; GENE DELETION; GENE EXPRESSION; GENE LOCATION; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; HUMAN; HUMAN TISSUE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RNA TRANSCRIPTION; TRINUCLEOTIDE REPEAT;

ALTERNATIVE SPLICING; ANIMALS; BLOTTING, WESTERN; BRAIN; CHO CELLS; CRICETINAE; CRICETULUS; EXONS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN ISOFORMS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; TAU PROTEINS; TISSUE DISTRIBUTION; TRANSFECTION;

EID: 35548931563     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm233     Document Type: Article

References (55)

1. Faustino, N.A. and Cooper, T.A. (2003) Pre-mRNA splicing and human disease. Genes Dev., 17, 419-437.
2. Garcia-Blanco, M.A., Baraniak, A.P. and Lasda, E.L. (2004) Alternative splicing in disease and therapy. Nat. Biotechnol., 22, 535-546.
3. Gallo, J.-M., Jin, P., Thornton, C.A., Lin, H., Robertson, J., D'Souza, I. and Schlaepfer, W.W. (2005) The role of RNA and RNA processing in neurodegeneration. J. Neurosci., 25, 10372-10375.
4. Licatalosi, D.D. and Darnell, R.B. (2006) Splicing regulation in neurologic disease. Neuron., 52, 93-101.
5. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H.H., Pickering Brown, S., Chakraverty, S., Isaacs, A., Grover, A. et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393, 702-704.
6. Poorkaj, P., Bird, T.D., Wijsman, E., Nemens, E., Garruto, R.M., Anderson, L., Andreadis, A., Wiederholt, W.C., Raskind, M. and Schellenberg, G.D. (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol., 43, 815-825.
7. Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A. and Ghetti, B. (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA 95, 7737-7741.
8. Caffrey, T.M., Joachim, C., Paracchini, S., Esiri, M.M. and Wade-Martins, R. (2006) Haplotype-specific expression of exon 10 at the human MAPT locus. Hum. Mol. Genet., 15, 3529-3537.
9. Myers, A.J., Pittman, A.M., Zhao, A.S., Rohrer, K., Kaleem, M., Marlowe, L., Lees, A., Leung, D., McKeith, I.G., Perry, R.H. et al. (2006) The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol. Dis., 25, 561-570.
10. McKee, A.E., Minet, E., Stern, C., Riahi, S., Stiles, C.D. and Silver, P.A. (2005) A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain. BMC Dev. Biol., 5, 14.
11. Jensen, K.B., Dredge, B.K., Stefani, G., Zhong, R., Buckanovich, R.J., Okano, H.J., Yang, Y.Y. and Darnell, R.B. (2000) Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron, 25, 359-371.
12. Ule, J., Ule, A., Spencer, J., Williams, A., Hu, J.S., Cline, M., Wang, H., Clark, T., Fraser, C., Ruggiu, M. et al. (2005) Nova regulates brain-specific splicing to shape the synapse. Nat. Genet., 37 844-852.
13. Margolis, R.L., Abraham, M.R., Gatchell, S.B., Li, S.H., Kidwai, A.S., Breschel, T.S., Stine, O.C., Callahan, C., McInnis, M.G. and Ross, C.A. (1997) cDNAs with long CAG trinucleotide repeats from human brain. Hum. Genet., 100, 114-122.
14. Gatchel, J.R. and Zoghbi, H.Y. (2005) Diseases of unstable repeat expansion: Mechanisms and common principles. Nat. Rev. Genet., 6, 743-755.
15. Butland, S.L., Devon, R.S., Huang, Y., Mead, C.L., Meynert, A.M., Neal, S.J., Lee, S.S., Wilkinson, A., Yang, G.S., Yuen, M.M. et al. (2007) CAG-encoded polyglutamine length polymorphism in the human genome. BMC. Genomics., 8, 126.
16. Ladd, A.N., Charlet, N. and Cooper, T.A. (2001) The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol., 21, 1285-1206.
17. Good, P.J., Chen, Q., Warner, S.J. and Herring, D.C. (2000) A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. J. Biol. Chem., 275, 28583-28592.
18. Ladd, A.N., Nguyen, N.H., Malhotra, K. and Cooper, T.A. (2004) CELF6, a member of the CELF family of RNA-binding proteins, regulates muscle-specific splicing enhancer-dependent alternative splicing. J. Biol. Chem., 279, 17756-17764.
19. Dev, A., Nayernia, K., Meins, M., Adham, I., Lacone, F. and Engel, W. (2007) Mice deficient for RNA-binding protein brunoll show reduction of spermatogenesis but are fertile. Mol. Reprod. Dev., 74, 1456-1464.
20. Ranum, L.P. and Cooper, T.A. (2006) RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci., 29, 259-277.
21. Wang, J., Gao, Q.S., Wang, Y., Lafyatis, R., Stamm, S. and Andreadis, A. (2004) Tau exon 10 whose missplicing causes frontotemporal dementia, is regulated by an-intricate interplay of cis elements and trans factors. J. Neurochem., 88, 1078-1090.
22. Ladd, A.N. and Cooper, T.A. (2004) Multiple domains control the subcellular localization and activity of ETR-3, a regulator of nuclear and cytoplasmic RNA processing events. J. Cell Sci., 117, 3519-3529.
23. Perez, M.K., Paulson, H.L., Pendse, S.J., Saionz, S.J., Bonini, N.M. and Pittman, R.N. (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J. Cell Biol., 143, 1457-1470.
24. Lee, W.-C.M., Yoshihara, M. and Littleton, J.T. (2004) Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl Acad. Sci. USA, 101, 3224-3229.
25. Narain, Y., Wyttenbach, A., Rankin, J., Furlong, R.A. and Rubinsztein, D.C. (1999) A molecular investigation of true dominance in Huntington's disease. J. Med. Genet., 36, 739-746.
26. Skinner, P.J., Koshy, B.T., Cummings, C.J., Klement, I.A., Relin, K., Servadio, A., Zoghbi, H.Y. and Orr, H.T. (1997) Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature, 389, 971-974.
27. Cummings, C.J., Mancini, M.A., Antalffy, B., DeFranco, D.B., Orr, H.T. and Zoghbi, H.Y. (1998) Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet., 19, 148-154.
28. Wyttenbach, A., Sauvageot, O., Carmichael, J., Diaz-Latoud, C., Arrigo, A.P. and Rubinsztein, D.C. (2002) Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum. Mol. Genet., 11, 1137-1151.
29. Yu, Q., Guo, J. and Zhou, J. (2004) A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10. J. Neurochem., 90, 164-172.
30. Mhatre, A.N., Trifiro, M.A., Kaufman, M., Kazemi-Esfarjani, P., Figlewicz, D., Rouleau, G. and Pinsky, L. (1993) Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat. Genet., 5, 184-188.
31. Butler, R., Leigh, P.N., McPhaul, M.J. and Gallo, M. (1998) Truncated forms of the androgen receptor are associated with polyglutamine expansion in X-linked spinal and bulbar muscular atrophy. Hum. Mol. Genet., 7, 121-127.
32. Ashman, J.B., Hall, E.S., Eveleth, J. and Boekelheide, K. (1992) Tau, the neuronal heat-stable microtubule-associated protein, is also present in the cross-linked microtubule network of the testicular spermatid manchette. Biol. Reprod., 46, 120-129.
33. Gu, Y., Oyama, F. and Ihara, Y. (1996) Tau is widely expressed in rat tissues. J. Neurochem., 67, 1235-1244.
34. Mukhopadhyay, D., Houchen, C.W., Kennedy, S., Dieckgraefe, B.K. and Anant, S. (2003) Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol. Cell 11, 113-126.
35. Anant, S., Henderson, J.O., Mukhopadhyay, D., Navaratnam, N., Kennedy, S., Min, J. and Davidson, N.O. (2001) Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J. Biol. Chem., 276, 47338-47351.
36. Aranda-Abreu, G.E., Behar, L., Chung, S., Fumeaux, H. and Ginzburg, I. (1999) Embryonic lethal abnormal vision-like RNA-binding proteins regulate neurite outgrowth and tau expression in PC12 cells. J Neurosci. 19, 6907-6917.
37. Aronov, S., Marx, R. and Ginzburg, I. (1999) Identification of 3′-UTR region implicated in tau mRNA stabilization in neuronal cells. J. Mol. Neurosci., 12, 131-145.
38. Singh, G., Charlet, B., Han, J. and Cooper, T.A. (2004) ETR-3 and CELF4 protein domains required for RNA binding and splicing activity in vivo. Nucleic Acids Res., 32, 1232-1241.
39. Han, J. and Cooper, T.A. (2005) Identification of CELF splicing activation and repression domains in vivo. Nucleic Acids Res., 33, 2769-2780.
40. Jiang, Z., Tang, H., Havlioglu, N., Zhang, X., Stamm, S., Yan, R. and Wu, J.Y. (2003) Mutations in tau gene exon10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2Β. J. Biol. Chem., 278, 18997-19007.
41. D'Souza, I. and Schellenberg, G.D. (2006) Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: Altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Δ280K and N279K. J. Biol. Chem., 281, 2460-2469.
42. Wu, J.Y., Kar, A., Kuo, D., Yu, B. and Havlioglu, N. (2006) SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy. Mol. Cell. Biol., 26, 6739-6747.
43. Wang, Y., Wang, J., Gao, L., Lafyatis, R., Stamm, S. and Andreadis, A. (2005) Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a complex comprised of SRp30c and SRp55 that either recruits or antagonizes htra2β1. J. Biol. Chem., 280, 14230-14239.
44. D'Souza, I. and Schellenberg, G.D. (2002) Tau exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5′ and 3′ splice sites. J. Biol. Chem., 277, 26587-26599.
45. Gao, L., Wang, J., Wang, Y. and Andreadis, A. (2007) SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations. Mol. Cell. Neurosci., 34, 48-58.
46. Kar, A., Havlioglu, N., Tarn, W.Y. and Wu, J.Y. (2006) RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion. J. Biol. Chem., 281, 24479-24488.
47. Faustino, N.A. and Cooper, T.A. (2005) Identification of putative new splicing targets for ETR-3 using sequences identified by systematic evolution of ligands by exponential enrichment. Mol. Cell. Biol., 25, 879-887.
48. Gromak, N., Matlin, A.J., Cooper, T.A. and Smith, C.W. (2003) Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein. RNA., 9, 443-456.
49. Vermersch, P., Sergeant, N., Ruchoux, M.M., Hofmann-Radvanyi, H., Wattez, A., Petit, H., Dwailly, P. and Delacourte, A. (1996) Specific tau variants in the brains of patients with myotonic dystrophy. Neurology, 47, 711-717.
50. Sergeant, N., Sablonniere, B., Schraen-Maschke, S., Ghestem, A., Maurage, C.A., Wattez, A., Vermersch, P. and Delacourte, A. (2001) Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet., 10, 2143-2155.
51. Jiang, H., Mankodi, A., Swanson, M.S., Moxley, R.T. and Thornton, C.A. (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet., 13, 3079-3088.
52. Leroy, O., Dhaenens, C.M., Schraen-Maschke, S., Belarbi, K., Delacourte, A., Andreadis, A., Sablonniere, B., Buee, L., Sergeant, N. and Caillet-Boudin, M.L. (2006) ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I. J. Neurosci. Res., 84, 852-859.
53. Donahue, C.P., Muratore, C., Wu, J.Y., Kosik, K.S. and Wolfe, M.S. (2006) Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing. J. Biol. Chem., 281, 23302-23306.
54. Hasegawa, M., Smith, M.J., Iijima, M., Tabira, T. and Goedert, M. (1999) FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett., 443, 93-96.
55. Rodriguez-Martin, T., Garcia-Blanco, M.A., Mansfield, S.G., Grover, A.C., Hutton, M., Yu, Q., Zhou, J., Anderton, B.H. and Gallo, M. (2005) Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: Implications for tauopathies. Proc. Natl Acad. Sci. USA, 102, 15659-15664.